LyricArtificial intelligence (AI)1 / 15Read in the app

Pitch deck

Lyric's pitch deck

The deck, and the 2 rounds we watched Lyric raise afterwards, with the investors each report named.

LYRIC BIO is a biotechnology and biomanufacturing company specializing in the production of donor-derived and protein-based therapeutics, particularly human immunoglobulin (Ig) products. The company is developing innovative bioreactors that utilize proprietary tissue engineering and laser-printed cellular substrate technology. This approach aims to enable scalable production from a single donor, reducing reliance on human donations. The core service of LYRIC BIO is its biomanufacturing platform designed for complex biologics. This platform supports continuous production of human immunoglobulin in ultra-high-density cell cultures, with the goal of improving access to essential medicines by addressing shortages and lowering costs. The company primarily focuses on IVIg and related immunoglobulin therapies, positioning itself as a key player in the manufacturing of donor-derived medicines for the biotechnology sector.

15 slides3.9MBUSArtificial intelligence (AI)Proptech

Read the deckFree account. The deck belongs to Lyric, so reading it needs one; everything on this page is public.

What is in it

The deck, slide by slide

Each slide by what it argues. 15 slides against a median of 13 across the 1,712 decks we hold.

median
  1. 1Cover
  2. 2Vision
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13Competition
  14. 14
  15. 15Contact

CoverVisionCompetitionContact

  1. Aug 2025

    Series B$44M

    Insight PartnersPrimary Venture PartnersVMG Partners

    Source recorded

  2. Apr 2019

    Series B$160M

    AirbnbLeadAdam BainBarry SternlichtDick CostoloFifthWallNEAObviousRXR RealtySignalFireSineWaveTishman SpeyerTusk

    Reported by VentureBeat

Everyone who backed Lyric

Lyric pitch deck, cover slide1 / 15

The deck itself

Read Lyric's full pitch deck

All 15 slides, each read for what it argues and set against the decks that raised at the same stage. The cover is shown here; the rest is read in the app.

Read the deck →Free account. The deck belongs to Lyric.

Investors who claim them

Firms listing Lyric on their own portfolio page: the firm's own account rather than a round we watched. Weaker than an announcement, much stronger than a list somebody sold us.

The Venture CollectiveVC firmNewBuild Venture CapitalVC firmAidenlair CapitalInvestment firm

More decks

SylveraArtificial intelligence (AI)1 / 8$308M raised afterDeep GenomicsArtificial intelligence (AI)1 / 14$197M raised afterFireworkArtificial intelligence (AI)1 / 10$152M raised afterPlentificArtificial intelligence (AI)1 / 11$136M raised after

Browse all 1,712 decks. We hold no record of where this file came from or on what terms. If it is yours and you would rather it were not here, tell us and it goes.